[A comparative evaluation of treatment methods for a genital papillomavirus infection in women with different viral genotypes].
Mikhaĭlov. I G IG; Maksimov. S Ia SIa; Novik. V I VI; Safronnikova. N R NR; Vishnevskiĭ. A S AS; Prianishnikov. V A VA; Lyshev. A A AA
Key Findings
- AVM plus cryo‑ or laser destruction beats either method alone for malignant HPV genotypes
- Cryodestruction alone (or with AVM) is most effective for benign HPV genotypes
- Treatment patterns repeat similarly in follow‑up courses
Practical Outcomes
- For biohackers interested in thymalin or anti‑aging protocols, this paper provides no actionable insight. It’s a clinical HPV treatment comparison, not a peptide or longevity study.
Summary
The study looked at different ways to treat cervical HPV infections, comparing cryodestruction, antiviral drugs, and combos with laser. It found that combining antivirals with cryo‑ or laser works best for high‑risk (malignant) HPV types, while cryodestruction alone is enough for low‑risk (benign) types. The research does not involve the peptide thymalin or offer any direct advice for longevity or performance hacking.
Abstract
Such genotypes of human papilloma virus (HPV) as "malignant" (180), "benign" (49) and indeterminate (127) were identified in 356 females by PCR and cytological procedures. The following therapeutic techniques were compared: cryodestruction of the uterine cervix (60), antiviral medication (AVM) (19), combination of AVM and cryodestruction (224), and combination of AVM and laser destruction (54). In the "malignant" HPV group, AVM in conjunction with cryo- or laser destruction was significantly more effective than cryodestruction or AVM alone. Both cryodestruction alone and in combination with AVM were more effective in treating "benign" genotypes. Repeat courses showed the same tendency.
Study Information
pubmed
2000